Showing results (1431-1440 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|February 24, 2018
A nationwide cross-sectional survey of pharmacy students on pharmacogenetic testing in The NetherlandsPaul Cd Bank, Jesse J Swen, Henk-Jan GuchelaarPharmacogenomics|December 5, 2017
Genetic variations of the xenoreceptors NR1I2 and NR1I3 and their effect on drug disposition and response variabilityLitaty Céphanoée Mbatchi, Jean-Paul Brouillet, Alexandre EvrardPharmacogenomics|July 6, 2016
Rapid identification of the NAT2 genotype in tuberculosis patients by multicolor melting curve analysisYanjie Hu, Suting Chen, Xia Yu, et al.Pharmacogenomics|October 7, 2017
Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount SinaiStuart A Scott, Aniwaa Owusu Obeng, Mariana R Botton, et al.Pharmacogenomics|February 23, 2018
BCL11A and MDR1 expressions have prognostic impact in patients with acute myeloid leukemia treated with chemotherapyGuo Xutao, Shi PengCheng, Li Yin, et al.Pharmacogenomics|February 23, 2018
Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemiaMaitane Umerez, Susana Garcia-Obregon, Idoia Martin-Guerrero, et al.Pharmacogenomics|February 23, 2018
Patient perspectives following pharmacogenomics results disclosure in an integrated health systemAmy A Lemke, Peter J Hulick, Dyson T Wake, et al.Pharmacogenomics|February 28, 2007
Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping SystemCarmen Dumaual, Xin Miao, Thomas M Daly, et al.Pharmacogenomics|September 20, 2006
A framework to evaluate the economic impact of pharmacogenomicsSarah C Stallings, Dan Huse, Stan N Finkelstein, et al.Pharmacogenomics|September 20, 2006
Pharmacogenomics of beta2-agonist: key focus on signaling pathwaysPallav Bhatnagar, Randeep Guleria, Ritushree KukretiPageof 276